Handelsbanken Fonder AB - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$646
+24.7%
11,000
-7.6%
0.00%0.0%
Q3 2023$518
-81.4%
11,900
-84.5%
0.00%
-80.0%
Q2 2023$2,778
-1.2%
76,900
+1.7%
0.02%
-6.2%
Q1 2023$2,811
-17.9%
75,6000.0%0.02%
-27.3%
Q4 2022$3,425
-99.9%
75,600
-0.1%
0.02%
-37.1%
Q3 2022$5,287,000
-4.2%
75,700
-7.9%
0.04%
-2.8%
Q2 2022$5,518,000
+28.6%
82,200
+57.5%
0.04%
+50.0%
Q1 2022$4,292,000
-43.9%
52,2000.0%0.02%
-36.8%
Q4 2021$7,657,000
-17.1%
52,2000.0%0.04%
-20.8%
Q3 2021$9,235,000
+35.5%
52,200
+23.7%
0.05%
+33.3%
Q2 2021$6,817,000
-48.3%
42,200
-45.1%
0.04%
-52.0%
Q1 2021$13,173,000
-26.8%
76,900
-6.1%
0.08%
-31.2%
Q4 2020$17,989,000
+33.6%
81,900
+1.0%
0.11%
+10.1%
Q3 2020$13,467,000
+21.1%
81,100
-16.7%
0.10%
+110.6%
Q2 2020$11,120,000
+285.7%
97,400
+159.7%
0.05%
-24.2%
Q1 2020$2,883,000
-29.0%
37,500
+19.0%
0.06%
-11.4%
Q4 2019$4,059,000
-7.8%
31,500
-44.2%
0.07%
-21.3%
Q3 2019$4,402,000
+4.2%
56,500
+37.8%
0.09%
+14.1%
Q2 2019$4,223,000
+44.0%
41,000
+2.5%
0.08%
+36.8%
Q1 2019$2,932,00040,0000.06%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$257,839,00068.01%
Boxer Capital, LLC 2,000,000$164,440,0008.45%
Avoro Capital Advisors LLC 5,325,000$437,822,0007.99%
M28 Capital Management LP 82,900$6,816,0006.27%
Artal Group S.A. 1,350,000$110,997,0004.65%
Nextech Invest Ltd. 173,300$14,249,0004.07%
Perceptive Advisors 2,380,710$195,742,0003.92%
Logos Global Management LP 350,000$28,777,0003.73%
Camber Capital Management LP 1,200,000$98,664,0003.57%
RTW INVESTMENTS, LP 1,561,497$128,386,0002.66%
View complete list of MIRATI THERAPEUTICS INC shareholders